The Alliance’s blog offers a personal, inside look at our activities and perspectives on a range of timely issues. We encourage your feedback.


Author: Breanna Bishop

Date: March 27th, 2017


Sarcopenia is the progressive loss of skeletal muscle that is linked to aging. Though the condition affects many older adults' functional abilities, it has not always garnered much public attention.

Groups such as the Aging in Motion Coalition have worked to raise awareness of sarcopenia and led efforts to secure an ICD-10-CM code for the condition. 

Sarcopenia is gaining even more recognition through the U.S. Food and Drug Administration's call for comments at an upcoming public meeting on Patient-Focused Drug Development (PFDD) for Sarcopenia on April 6, 2017, from 1 to 5 p.m. EST.

If you or someone you know has sarcopenia, the FDA wants to hear from you!

You can participate in the meeting in person or virtually through a live webcast.

If you're interested in attending in person, the meeting will be held at the Tommy Douglas Conference Center in Silver Spring, Md. Registration for the meeting ends on March 27, 2017. You can find registration details here

If you're unable to join the meeting and cannot watch online, you can also offer comments through the public docket. Comments can be sent electronically or through the U.S. mail. All submissions must include the Docket No. FDA-2016-N-4198 for “Public Meeting on Patient-Focused Drug Development for Sarcopenia; Request for Comments." The docket closes on June 6, 2017. For more, please go here.

A Tribute to a Great Scientist

Author: Dan Perry

Date: March 11th, 2008

FDA Needs More Funding to Fulfill Its Mission

Author: Cynthia Bens

Date: March 18th, 2008

Spending or Investing? -- The Silver Book & Innovation

Author: Lindsay Clarke

Date: March 26th, 2008

Preventing the Flu: A Q & A with Dr. William Schaffner

Author: Noel Lloyd

Date: December 4th, 2017

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

Author: Phyllis Greenberger

Date: December 1st, 2017

An Update on the Clinical Trials for Alzheimer’s Disease Conference

Author: Noel Lloyd

Date: November 7th, 2017

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It